Orchard Therapeutics plc (ORTX) Financial Statements (2026 and earlier)

Company Profile

Business Address	245 HAMMERSMITH ROAD, 3RD FLOOR LONDON, W6 8PW
State of Incorp.
Fiscal Year End	December 31
Industry (SIC)	2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info	Complete Financial Analysis Financial Benchmarking

	6/30/2023 Q2	3/31/2023 Q1	12/31/2022 Q4	9/30/2022 Q3	6/30/2022 Q2	3/31/2022 Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:	150,700	146,300	143,800	146,600	170,900	199,000
Cash and cash equivalent	38,273	61,487	68,424	80,751	53,470	60,775
Other undisclosed cash, cash equivalents, and short-term investments	112,427	84,813	75,376	65,849	117,430	138,225
Receivables	9,966	1,020	10,318	6,559	6,406	6,874
Inventory, net of allowances, customer advances and progress billings	6,937	5,555	3,400	2,334	1,919	1,799
Inventory	6,937	5,555	3,400	2,334	1,919	1,799
Prepaid expense	2,998	3,999	1,817	1,950	3,579	4,976
Other undisclosed current assets	10,689	9,326	8,810	21,810	22,519	24,789
Total current assets:	181,290	166,200	168,145	179,253	205,323	237,438
Noncurrent Assets
Operating lease, right-of-use asset	21,018	21,904	22,774	23,133	25,455	27,368
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization	7,808	8,149	8,138	7,804	5,733	4,454
Intangible asset, including goodwill, after accumulated amortization	3,474	3,518	3,560	3,487	3,736	3,993
Intangible asset, excluding goodwill, after accumulated amortization	3,474	3,518	3,560	3,487	3,736	3,993
Regulated entity, other noncurrent assets	203	225		266	290	311
Restricted cash and investments	4,215	4,215	4,215	4,266	4,266	4,266
Other noncurrent assets	12,396	12,262	12,075	11,795	10,696	10,731
Other undisclosed noncurrent assets	1,898	544		4,046	3,660	2,944
Total noncurrent assets:	51,012	50,817	50,762	54,797	53,836	54,067
TOTAL ASSETS: